A critical discovery in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This crucial cancer protector protein is frequently disabled in several forms of malignancies, resulting https://telebookmarks.com/story12598345/mini-antibodies-reactivate-the-p53-protein-a-potential-pathway-for-malignant-management